Virtual Reality Exergaming for Cerebral Palsy

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Children's Hospital of Alabama, Birmingham, AL
Cerebral Palsy
Virtual Reality Exergaming - Behavioral
Eligibility
< 65
All Sexes
What conditions do you have?
Select

Study Summary

The primary purpose of this study is to examine the preliminary efficacy of 12-weeks of home-based exercise using consumer available virtual reality gaming technology, compared with a 12 week wait-list control group. The secondary purpose is to understand behavioral mechanisms that explain participation in exergaming through semi-structured interviews with participants from both groups at post-intervention or dropout.

Treatment Effectiveness

Study Objectives

9 Primary · 5 Secondary · Reporting Duration: Week 0, Week 6, Week 12

Week 12
Changes in C-reactive protein (hsCRP)
Changes in Hemoglobin A1C
Changes in fasting insulin
Changes in fasting triglycerides
Changes in high-density lipoprotein
Changes in low-density lipoprotein
Changes in resting diastolic blood pressure
Changes in resting systolic blood pressure
Changes in total cholesterol
Week 13
Participants perceptions of completing the intervention
Weeks 1-12
Adherence to the exercise intervention prescription
Compliance to the intervention coaching calls
Compliance to the remote data collections
Total intervention play time

Trial Safety

Trial Design

2 Treatment Groups

Wait-list Control
1 of 2
Immediate Start - Virtual Reality Exergaming
1 of 2
Active Control
Experimental Treatment

34 Total Participants · 2 Treatment Groups

Primary Treatment: Virtual Reality Exergaming · No Placebo Group · Phase 1

Immediate Start - Virtual Reality Exergaming
Behavioral
Experimental Group · 1 Intervention: Virtual Reality Exergaming · Intervention Types: Behavioral
Wait-list ControlNoIntervention Group · 1 Intervention: Wait-list Control · Intervention Types:

Trial Logistics

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: week 0, week 6, week 12
Closest Location: Children's Hospital of Alabama · Birmingham, AL
Photo of Birmingham 1Photo of Birmingham 2Photo of Birmingham 3
2004First Recorded Clinical Trial
2 TrialsResearching Cerebral Palsy
73 CompletedClinical Trials

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,402 Previous Clinical Trials
2,211,029 Total Patients Enrolled
4 Trials studying Cerebral Palsy
192 Patients Enrolled for Cerebral Palsy
Byron Lai, PhDPrincipal InvestigatorUniversity of Alabama at Birmingham

Eligibility Criteria

Age < 65 · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have been approved by your physician to participate in the study.
You have access to a Wi-Fi Internet connection in the home via mobile phone or tablet computer.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.